Akers Biosciences Announces a Change to the Board of Directors THOROFARE, N.J., May 29, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, announces...

Akers Biosciences Withdraws FDA 510(k) Submission for PIFA Chlamydia Rapid Assay Pending Further Evaluation THOROFARE, N.J., May 29, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, announces...

Smith-Midland Signs Largest Contract in Company's History MIDLAND, VA , April 12, 2018 (GLOBE NEWSWIRE) -- Smith-Midland Corporation (OTCQX: SMID) project announcement. FAM Construction, LLC (a Ferrovial Agroman US and Allan Myers joint venture) has...

Akers Biosciences Reports Earnings for Fiscal Year 2017 Total Revenue Up 33% THOROFARE, N.J., April 03, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers”, “Akers Bio” or the "Company"), a developer of rapid health...

Akers Biosciences Announces Rescheduled Conference Call to Discuss Fiscal Year 2017 Earnings THOROFARE, N.J., March 28, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, will...